Guest Column | April 30, 2013

The FDA's Clock Is Ticking – Why Those 15 Days Are Critical

Joseph Pinkett

When many companies respond to an FDA 483, they tend to address each specific violation in their response letter. Although they are addressing the individual complaints, they never actually get down to solving the underlying problems.

Developing a response letter that addresses the inspectional observations as well as the underlying problems has gotten more challenging. The agency is now putting more pressure on drug manufacturers to answer within 15 workdays after an inspection closes out. The clock is ticking, and your time is running out!

access the Guest Column!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader